Find Trials Near
Speak with a clinical trials expert
(904) 328-1061
Have multiple conditions? Click here

You are viewing Clinical Trials in Jacksonville, Florida

Map View Full Map View Map

Refine your Search

helpful resources
browse trials by condition
  • Sort By:
  • Title
  • City
  • State
  • Zip

NEW Clinical Evaluation of Lapsed Contact Lens Wearers Who Are Re-fit Into Senofilcon A Contact Lenses (Phase 1)

Jacksonville
Florida
32209
Age: 18 - 40
Conditions:

NEW A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus

Jacksonville
Florida
32209
Age: 30 - Any
Conditions: Diabetes, Endocrine

NEW A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus

Jacksonville
Florida
32209
Age: 30 - Any
Conditions: Diabetes, Endocrine

NEW Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma

Jacksonville
Florida
32207
Age: Any - 21
Conditions: Lymphoma

NEW A Phase 1B Dose-escalation and Phase 2a Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

Jacksonville
Florida
32224
Age: 18 - Any
Conditions:

NEW The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Peripheral Vascular Disease

NEW The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Jacksonville
Florida
32207
Age: 18 - Any
Conditions: Peripheral Vascular Disease

NEW The SENTRY Clinical Study

Jacksonville
Florida
32209
Age: 18 - Any
Conditions: Cardiology

NEW BIIB017 (PEGylated Interferon Beta-1a) Related Flu-Like Symptoms in Relapsing Multiple Sclerosis Participants

Jacksonville
Florida
32209
Age: 18 - 65
Conditions: Neurology

NEW A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer

Jacksonville
Florida
Age: 18 - Any
Conditions: Cancer, Colorectal Cancer

NEW A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer

Jacksonville
Florida
32034
Age: 18 - Any
Conditions: Cancer, Colorectal Cancer

NEW A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer

Jacksonville
Florida
32034
Age: 18 - Any
Conditions: Cancer, Colorectal Cancer

NEW A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer

Jacksonville
Florida
32034
Age: 18 - Any
Conditions: Cancer, Colorectal Cancer

NEW A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer

Jacksonville
Florida
32034
Age: 18 - Any
Conditions: Cancer, Colorectal Cancer

NEW Pediatric Open-Label Extension Study

Jacksonville
Florida
32216
Age: 6 - 17
Conditions: Autism, Depression, Neurology, Psychiatric, Schizophrenia

NEW Treatment for CI-DME in Eyes With Very Good VA Study

Jacksonville
Florida
32209
Age: 18 - Any
Conditions: Cardiology, Ocular

NEW Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Diabetes

NEW Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Diabetes

NEW Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Diabetes

NEW Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Diabetes

NEW Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

Jacksonville
Florida
32207
Age: Any - 29
Conditions: Blood Cancer, Hematology, Infectious Disease, Lymphoma

NEW Implementing an Emergency Department to Home Care Transition Intervention

Jacksonville
Florida
32209
Age: 60 - Any
Conditions: Hospital

NEW Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis

Jacksonville
Florida
32209
Age: 18 - Any
Conditions: Blood Cancer, Cancer, Hematology

NEW Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia

Jacksonville
Florida
32209
Age: 18 - 80
Conditions: Pneumonia

NEW Shared Decision Making in the Emergency Department: Chest Pain Choice Trial

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Angina, Cardiology, Hospital

NEW Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

Jacksonville
Florida
32209
Age: 55 - 85
Conditions: Alzheimer Disease, Neurology

NEW Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events

Jacksonville
Florida
32205
Age: 18 - Any
Conditions: High Cholesterol

NEW Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: High Cholesterol

NEW Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: High Cholesterol

NEW Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: High Cholesterol

NEW Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events

Jacksonville
Florida
32277
Age: 18 - Any
Conditions: High Cholesterol

NEW Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events

Jacksonville
Florida
32204
Age: 18 - Any
Conditions: High Cholesterol

NEW A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Jacksonville
Florida
32209
Age: 30 - Any
Conditions: Parkinsons Disease

NEW Best African American Response to Asthma Drugs

Jacksonville
Florida
32207
Age: 5 - Any
Conditions: Asthma

NEW A Study of Kadcyla (Trastuzumab Emtansine) Plus Perjeta (Pertuzumab) Following Anthracyclines in Comparison With Herceptin (Trastuzumab) Plus Perjeta and a Taxane Following Anthracyclines as Adjuvant Therapy in Patients With Operable HER2-Positive Primary Breast Cancer

Jacksonville
Florida
32209
Age: 18 - Any
Conditions: Breast Cancer, Cancer

NEW Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients With Moderate to Very Severe COPD

Jacksonville
Florida
32216
Age: 40 - Any
Conditions: Chronic Obstructive Pulmonary Disease, Pulmonary

NEW Long Term Safety of Naldemedine

Jacksonville
Florida
Age: 18 - 80
Conditions: Constipation

NEW A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

Jacksonville
Florida
32209
Age: 18 - Any
Conditions: Arthritis, Rheumatoid Arthritis

NEW A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events

Jacksonville
Florida
32216
Age: 50 - Any
Conditions: Diabetes

NEW A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events

Jacksonville
Florida
32216
Age: 50 - Any
Conditions: Diabetes

NEW A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events

Jacksonville
Florida
32216
Age: 50 - Any
Conditions: Diabetes

NEW Improving Outcomes in Neonatal Abstinence Syndrome

Jacksonville
Florida
Age: Any
Conditions: Psychiatric

NEW SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Jacksonville
Florida
32224
Age: 18 - Any
Conditions: Blood Cancer, Hematology

NEW Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

Jacksonville
Florida
32224
Age: 18 - Any
Conditions: Cancer, Prostate Cancer

NEW Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

Jacksonville
Florida
32207
Age: 65 - Any
Conditions: Influenza

NEW Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy

Jacksonville
Florida
32256
Age: 18 - 65
Conditions: Depression, Major Depression Disorder (MDD)

NEW Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Diabetes

NEW A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure

Jacksonville
Florida
32209
Age: 18 - 95
Conditions: Cardiology, Neurology, Peripheral Vascular Disease

NEW Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Cardiology

NEW Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Cardiology

NEW Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Cardiology

NEW The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes

Jacksonville
Florida
32216
Age: 18 - 75
Conditions: Diabetes

NEW A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

Jacksonville
Florida
32216
Age: 1 - 17
Conditions: Diabetes

NEW Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer

Jacksonville
Florida
32207
Age: 2 - 12
Conditions: Cancer

NEW Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)

Jacksonville
Florida
32209
Age: 18 - Any
Conditions: Cardiology

NEW Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)

Jacksonville
Florida
32209
Age: 18 - Any
Conditions: Cardiology

NEW Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Jacksonville
North Carolina
28546
Age: 18 - Any
Conditions: Skin Cancer

NEW A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

Jacksonville
Florida
32256
Age: 18 - Any
Conditions: Breast Cancer

NEW A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure

Jacksonville
Florida
32216
Age: 18 - 75
Conditions: Cardiology

NEW Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects

Jacksonville
Florida
32256
Age: 2 - 75
Conditions: Crohns Disease

NEW A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms

Jacksonville
Florida
32207
Age: 40 - 65
Conditions: Women's Studies

NEW Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients

Jacksonville
Florida
32209
Age: 18 - 80
Conditions: High Cholesterol

NEW A Study of SI-6603 in Patients With Lumbar Disc Herniation

Jacksonville
Florida
32209
Age: 30 - 70
Conditions: Orthopedic

NEW Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B

Jacksonville
Florida
32216
Age: 18 - 55
Conditions: Infectious Disease

NEW Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B

Jacksonville
Florida
32205
Age: 18 - 55
Conditions: Infectious Disease

NEW Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents

Jacksonville
Florida
32209
Age: 18 - 75
Conditions: Diabetes, High Blood Pressure (Hypertension)

NEW A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 (HIV-1) Coinfection

Jacksonville
Florida
32209
Age: 18 - 70
Conditions: Gastrointestinal, Hepatitis, HIV / AIDS, Infectious Disease

NEW Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)

Jacksonville
Florida
32224
Age: 21 - Any
Conditions: ALS, Neurology

NEW Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)

Jacksonville
Florida
32209
Age: 21 - Any
Conditions: ALS, Neurology

NEW Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Jacksonville
Florida
32209
Age: 18 - Any
Conditions: Gastrointestinal

NEW Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age

Jacksonville
Florida
32207
Age: 21 - 64
Conditions: Influenza

NEW A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain

Jacksonville
Florida
32209
Age: 18 - 49
Conditions: Endometriosis, Women's Studies

NEW Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis

Jacksonville
Florida
32224
Age: 18 - Any
Conditions: Osteoarthritis (OA)

NEW Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin

Jacksonville
Florida
32207
Age: 30 - 64
Conditions: Diabetes

NEW Longitudinal Study of Patients With Opioid-Induced Constipation

Jacksonville
Florida
32216
Age: 18 - 85
Conditions: Constipation

NEW Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)

Jacksonville
Florida
32209
Age: 18 - Any
Conditions: High Cholesterol

NEW Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Jacksonville
Florida
32256
Age: 18 - Any
Conditions: Gastrointestinal, Infectious Disease

NEW Two Part Study to Study Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir (EVG) Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Subjects

Jacksonville
Florida
32209
Age: Any - 17
Conditions: HIV / AIDS

NEW Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets

Jacksonville
Florida
Age: 18 - 80
Conditions: Back Pain

NEW Trinity™ BIOLOX Delta™ CoC THR Multi-center Study

Jacksonville
Florida
32224
Age: 18 - 80
Conditions: Arthritis, Orthopedic, Osteoarthritis (OA), Rheumatoid Arthritis

NEW Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction

Jacksonville
Florida
32216
Age: 55 - Any
Conditions: Cardiology

NEW Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction

Jacksonville
Florida
32216
Age: 55 - Any
Conditions: Cardiology

NEW Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients

Jacksonville
Florida
32209
Age: 18 - 80
Conditions: Endocrine

NEW Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients

Jacksonville
Florida
32209
Age: 18 - 80
Conditions: Endocrine

NEW Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist

Jacksonville
Florida
32209
Age: 12 - 75
Conditions: Asthma

NEW Pediatric Autism Study

Jacksonville
Florida
32216
Age: 6 - 17
Conditions: Autism, Neurology, Psychiatric

NEW Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Psoriasis

NEW Follow up Study to Assess Safety, Treatment Efficacy and Adherence of OX219 (Buprenorphine/Naloxone).

Jacksonville Metropolitan area
Florida
Age: 18 - 65
Conditions: Gastrointestinal

NEW A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

Jacksonville
Florida
32209
Age: 18 - Any
Conditions: Hospital, Post-Surgical Pain

NEW A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

Jacksonville
Florida
32209
Age: 18 - Any
Conditions: Hospital, Post-Surgical Pain

NEW A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

Jacksonville
Florida
32224
Age: 18 - Any
Conditions: Cancer, Ovarian Cancer

NEW MEK162 for Patients With RAS/RAF/MEK Activated Tumors

Jacksonville
Florida
32256
Age: 18 - Any
Conditions:

NEW Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

Jacksonville
Florida
32224
Age: 18 - Any
Conditions: Breast Cancer, Cancer

NEW Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Diabetes

NEW Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Diabetes

NEW Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Diabetes

NEW A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

Jacksonville
Florida
32209
Age: 18 - Any
Conditions: Blood Cancer, Hematology

NEW Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Jacksonville
Florida
32216
Age: 18 - Any
Conditions: Neurology

NEW Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia

Jacksonville
Florida
32209
Age: 18 - 69
Conditions: High Cholesterol, Metabolic

NEW Beraprost-314d Added-on to Tyvaso® (BEAT)

Jacksonville
Florida
32216
Age: 18 - 80
Conditions: High Blood Pressure (Hypertension)
View Clinical Trial Facilities in Florida
Return to Search Results
Updating search results
One moment     loading
BROWSE CLINICAL TRIALS BY STATE
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
Featured Locations: Anaheim - Atlanta - Birmingham - Cleveland - DeLand - Jacksonville - Miami - Oklahoma City
Copyright 2015 Clinical Trials GPS | All Rights Reserved
About Us | Contact Us | Privacy Policy | Terms of Service | Archive | Sitemap
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site
Get connected to the right trial.
Create your account

Tell Us About Yourself


Are you healthy?
Do You Smoke
Overnight stay?
Phase:
Find Trials for the Following Conditions (choose all that apply)
  • Cardiology / Vascular Diseases






  • Dental / Maxillofacial Surgery

  • Dermatology / Plastic Surgery







  • Endocrinology





  • Gastroenterology










  • Hematology




  • Immunology / Infectious Diseases










  • Musculoskeletal




  • Nephrology / Urology






  • Neurology





  • Oncology


















  • Ophthalmology

  • Orthopedics / Podiatry



  • Other













  • Otolaryngology


  • Pharmacology / Toxicology


  • Psychiatry / Psychology









  • Pulmonary / Respiratory Diseases









  • Reproductive








  • Rheumatology










Thanks for submitting your information!
You will be contacted by one of our Clinical Trials Specialists to help guide you through the process of finding the right trial for you!
Based on your responses, we have a few additional questions (optional):
TAKE ME BACK TO THE HOMEPAGE
✖



Forgot Password?
✖

✖